328 related articles for article (PubMed ID: 17991931)
1. Patient-reported outcomes and the evolution of adverse event reporting in oncology.
Trotti A; Colevas AD; Setser A; Basch E
J Clin Oncol; 2007 Nov; 25(32):5121-7. PubMed ID: 17991931
[TBL] [Abstract][Full Text] [Related]
2. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
[TBL] [Abstract][Full Text] [Related]
3. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Chung AE; Shoenbill K; Mitchell SA; Dueck AC; Schrag D; Bruner DW; Minasian LM; St Germain D; O'Mara AM; Baumgartner P; Rogak LJ; Abernethy AP; Griffin AC; Basch EM
J Am Med Inform Assoc; 2019 Apr; 26(4):276-285. PubMed ID: 30840079
[TBL] [Abstract][Full Text] [Related]
4. Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Kluetz PG; Chingos DT; Basch EM; Mitchell SA
Am Soc Clin Oncol Educ Book; 2016; 35():67-73. PubMed ID: 27249687
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
[TBL] [Abstract][Full Text] [Related]
6. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
[TBL] [Abstract][Full Text] [Related]
7. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
Basch E; Reeve BB; Mitchell SA; Clauser SB; Minasian LM; Dueck AC; Mendoza TR; Hay J; Atkinson TM; Abernethy AP; Bruner DW; Cleeland CS; Sloan JA; Chilukuri R; Baumgartner P; Denicoff A; St Germain D; O'Mara AM; Chen A; Kelaghan J; Bennett AV; Sit L; Rogak L; Barz A; Paul DB; Schrag D
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25265940
[TBL] [Abstract][Full Text] [Related]
8. Supporting quality and patient safety in cancer clinical trials.
Badalucco S; Reed KK
Clin J Oncol Nurs; 2011 Jun; 15(3):263-5. PubMed ID: 21624861
[TBL] [Abstract][Full Text] [Related]
9. The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.
Reeve BB; Withycombe JS; Baker JN; Hooke MC; Lyons JC; Mowbray C; Wang J; Freyer DR; Joffe S; Sung L; Tomlinson D; Gold SH; Hinds PS
Pediatr Blood Cancer; 2013 Jul; 60(7):1231-6. PubMed ID: 23335328
[TBL] [Abstract][Full Text] [Related]
10. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
Banerjee AK; Okun S; Edwards IR; Wicks P; Smith MY; Mayall SJ; Flamion B; Cleeland C; Basch E;
Drug Saf; 2013 Dec; 36(12):1129-49. PubMed ID: 24092596
[TBL] [Abstract][Full Text] [Related]
11. Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Hay JL; Atkinson TM; Reeve BB; Mitchell SA; Mendoza TR; Willis G; Minasian LM; Clauser SB; Denicoff A; O'Mara A; Chen A; Bennett AV; Paul DB; Gagne J; Rogak L; Sit L; Viswanath V; Schrag D; Basch E;
Qual Life Res; 2014 Feb; 23(1):257-69. PubMed ID: 23868457
[TBL] [Abstract][Full Text] [Related]
12. Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.
Basch E; Rogak LJ; Dueck AC
Clin Ther; 2016 Apr; 38(4):821-30. PubMed ID: 27045992
[TBL] [Abstract][Full Text] [Related]
13. Is there room for improvement in adverse event reporting in the era of targeted therapies?
Edgerly M; Fojo T
J Natl Cancer Inst; 2008 Feb; 100(4):240-2. PubMed ID: 18270340
[TBL] [Abstract][Full Text] [Related]
14. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G; Morris C; Velikova G
Ann Oncol; 2017 Sep; 28(9):2305-2311. PubMed ID: 28911065
[TBL] [Abstract][Full Text] [Related]
15. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
[TBL] [Abstract][Full Text] [Related]
16. Adverse event reporting in publications compared with sponsor database for cancer clinical trials.
Scharf O; Colevas AD
J Clin Oncol; 2006 Aug; 24(24):3933-8. PubMed ID: 16921045
[TBL] [Abstract][Full Text] [Related]
17. Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.
Miller TP; Fisher BT; Getz KD; Sack L; Razzaghi H; Seif AE; Bagatell R; Adamson PC; Aplenc R
Pediatr Blood Cancer; 2019 Jul; 66(7):e27747. PubMed ID: 30968531
[TBL] [Abstract][Full Text] [Related]
18. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Basch E; Becker C; Rogak LJ; Schrag D; Reeve BB; Spears P; Smith ML; Gounder MM; Mahoney MR; Schwartz GK; Bennett AV; Mendoza TR; Cleeland CS; Sloan JA; Bruner DW; Schwab G; Atkinson TM; Thanarajasingam G; Bertagnolli MM; Dueck AC
Clin Trials; 2021 Feb; 18(1):104-114. PubMed ID: 33258687
[TBL] [Abstract][Full Text] [Related]
19. Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General Oncology.
Kennedy F; Absolom K; Clayton B; Rogers Z; Gordon K; O'Connell Francischetto E; Blazeby JM; Brown J; Velikova G
JCO Oncol Pract; 2021 Mar; 17(3):e386-e396. PubMed ID: 32853122
[TBL] [Abstract][Full Text] [Related]
20. Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.
Yoon J; Sim SH; Kang D; Han G; Kim Y; Ahn J; Oh D; Lee ES; Kong SY; Cho J; Mitchell SA
J Pain Symptom Manage; 2020 May; 59(5):1082-1088.e6. PubMed ID: 32044423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
